A nurse is caring for a patient with acute decompensated heart failure who develops cardiogenic shock. The patient's blood pressure is 85/55 mmHg, heart rate is 130 bpm, and urine output has decreased to 10 mL/hr. Which nursing intervention should be the priority?
1Administer IV fluid bolus to increase preload
2Position the patient in Trendelenburg position
3Prepare for immediate cardioversion
4Administer prescribed inotropic medications✓ 정답
해설
Inotropic medications are the priority in cardiogenic shock as they directly increase myocardial contractility to improve cardiac output and tissue perfusion. Other interventions like fluid bolus or Trendelenburg position may not address the underlying pump failure effectively.
In managing a patient with acute decompensated heart failure (ADHF) who has decompensated into cardiogenic shock, the clinical presentation of hypotension (85/55 mmHg), reflex tachycardia (130 bpm), and oliguria (10 mL/hr) signals a state of severe end-organ hypoperfusion. The priority intervention is to restore cardiac output and tissue perfusion by improving myocardial contractility, making the administration of prescribed inotropic medications the correct answer.
Understanding the Pathophysiology of the Presentation Cardiogenic shock is a life-threatening condition caused by the heart's sudden inability to pump sufficient blood to maintain adequate tissue perfusion, most commonly occurring following a myocardial infarction or acute decompensated heart failure . The primary problem is pump failure, not volume loss. In ADHF, the left ventricle is often overloaded and failing, leading to pulmonary congestion and poor forward flow. The resultant hypoperfusion can quickly progress to end-organ failure and ultimately death if not treated urgently . The patient’s low blood pressure and negligible urine output confirm that the heart’s contractile force is insufficient to perfuse the kidneys and other vital organs.
Analysis of the Priority Intervention: Inotropic Support
The cornerstone of pharmacological therapy in this scenario is an inotropic agent (such as dobutamine or milrinone). These medications work by directly stimulating cardiac beta-1 receptors or inhibiting phosphodiesterase to increase intracellular calcium in myocardial cells, thereby enhancing cardiac contractility. By increasing the force of myocardial contraction, inotropes improve stroke volume and cardiac output, which in turn raises blood pressure and restores perfusion to vital organs like the kidneys . This directly addresses the root cause of the patient’s decompensation. The SCAI/EAPCI/ACVC expert consensus highlights that timely delivery of optimal treatment for cardiogenic shock is critical to improving outcomes, as delays in appropriate therapy contribute to poor survival rates [2].
Why the Other Options Are Incorrect or Lower Priority
- Administer IV fluid bolus to increase preload (Option 1): This is potentially harmful. In cardiogenic shock secondary to ADHF, the ventricle is already failing and volume-overloaded. Administering a fluid bolus increases preload on a heart that cannot effectively pump the existing volume, which can worsen pulmonary edema and further compromise cardiac function without improving perfusion. Fluid resuscitation is reserved for shock states where hypovolemia is the primary cause, not pump failure.
- Position the patient in Trendelenburg position (Option 2): This is an outdated and inappropriate intervention for cardiogenic shock. The Trendelenburg position (head down, feet elevated) is meant to promote venous return in hypovolemic states. In a patient with a failing, congested heart, this position increases venous return to an already struggling right heart and may exacerbate respiratory distress from pulmonary congestion by shifting abdominal contents against the diaphragm. The current evidence supports keeping the patient in a position that optimizes oxygenation, not one that increases preload on a failing pump.
- Prepare for immediate cardioversion (Option 3): While the patient is tachycardic at 130 bpm, this is most likely a sinus tachycardia—a compensatory mechanism for the low cardiac output and hypotension. Cardioversion is indicated for hemodynamically unstable tachydysrhythmias (e.g., atrial fibrillation with rapid ventricular response, ventricular tachycardia) that are the primary cause of the instability. Here, the tachycardia is a symptom of the shock, not the cause. Treating the underlying pump failure with inotropes will likely resolve the compensatory tachycardia. Performing cardioversion on a compensatory rhythm would not correct the underlying problem and could cause cardiac arrest.
References (research sources)
[2]
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women: This statement was endorsed by the Heart Failure Society of America (HFSA).GuidelineBaron SJ, Chou JC, Shah T, Vest AR, Abbott JD, Alasnag M, Aurigemma C, Barbato E, Bellumkonda L, Bortnick AE, Chieffo A, Geuns RV, Grines CL, Halvorsen S, Hassager C, Kapur NK, Naidu SS, Ng VG, Saw J, Lansky AJ. (2025) · DOI: 10.1016/j.jscai.2024.102150
Clinical Practice Guide: Cardiogenic Shock in ADHF
Congestion: Pulmonary crackles, elevated JVP, peripheral edema (may be present due to underlying ADHF).
2. Immediate Nursing Priorities
Pharmacologic Support: Administer prescribed inotropes (e.g., dobutamine, milrinone) as first-line therapy to enhance contractility. Vasopressors (e.g., norepinephrine) may be added if hypotension persists despite inotropy.
Avoid Harmful Interventions: Do not administer rapid IV fluid boluses unless specifically indicated for right ventricular infarction; this can precipitate pulmonary edema in left ventricular failure.
Monitoring: Continuous telemetry, hourly urine output via indwelling catheter, frequent blood pressure monitoring, and pulse oximetry. Prepare for invasive hemodynamic monitoring (arterial line, central line).
3. Ongoing Management and Reassessment
Evaluate Response: Titrate inotropes to achieve target MAP > 65 mmHg, improved mental status, and urine output > 30 mL/hr. Monitor for dysrhythmias, a common adverse effect of inotropic therapy.
Identify Etiology: Prepare for 12-lead ECG and echocardiogram to rule out acute MI or mechanical complications. Anticipate transfer to a cardiac intensive care unit.
Patient Safety: Maintain semi-Fowler's position to optimize ventilation unless contraindicated. Provide emotional support and clear explanations to reduce anxiety and myocardial oxygen demand.
Cardiogenic Shock — A life-threatening condition where the heart suddenly cannot pump enough blood to meet the body's needs, often due to severe pump failure from myocardial infarction or acute decompensated heart failure.
Inotropic Medications — Agents such as dobutamine or milrinone that increase the force of myocardial contraction, thereby improving cardiac output and tissue perfusion in states of pump failure.
End-Organ Hypoperfusion — Inadequate blood flow to vital organs, manifested clinically by signs such as decreased urine output (renal), altered mental status (cerebral), or cool extremities (skin).